IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goralczyk, R.
Right arrow Articles by Bausch, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goralczyk, R.
Right arrow Articles by Bausch, J.
(Investigative Ophthalmology and Visual Science. 2000;41:1513-1522.)
© 2000 by The Association for Research in Vision and Ophthalmology, Inc.

Dose Dependency of Canthaxanthin Crystals in Monkey Retina and Spatial Distribution of its Metabolites

Regina Goralczyk1, Felix M. Barker2, Susanne Buser3, Hans Liechti1 and Jochen Bausch1

From 1 Vitamins and Fine Chemicals, Human Nutrition and Health, and 3 Pharma Division, Preclinical Research, Department of Toxicology, Basel, Switzerland; and 2 Hafter Family Light and Laser Institute, Pennsylvania College of Optometry, Philadelphia.

PURPOSE. To establish the threshold level of canthaxanthin crystals in the retina of cynomolgus monkeys. To correlate the spatial distribution of all-trans canthaxanthin and its metabolites with the grade of CRYSTALS. METHODS. Monkeys were orally administered 0, 0.2, 0.6, 1.8, 5.4, 16.2, and 48.6 mg/kg body wt canthaxanthin daily for 2.5 to 3 years. A second group of monkeys were administered 200 and 500 mg/kg body wt/d for 5 years. Ophthalmoscopy, electroretinography (ERG), retina and carotenoid analysis were performed as previously reported.

RESULTS. Crystals in the retina periphery were observed by ophthalmoscopy preterminally only in the extreme high doses of 200 to 500 mg/kg body wt/d. There were no adverse effects on visual functions as measured by ERG. Crystals in the peripheral retina, and/or in the macula, were detected microscopically in all canthaxanthin treated groups except at the lowest dose of 0.2 mg/kg body wt/d. The grade of crystals increased up to a dose of 16.2 mg/kg body wt/d. Dose-dependent increases in canthaxanthin content also were noted in the retina, the liver, and in plasma. All-trans canthaxanthin was the major compound in the peripheral and paracentral retina of very highly dosed animals, where its concentration correlated largely with the grade of inclusions. In the macula, 4'-OH-echinenone was the dominant canthaxanthin METABOLITE. CONCLUSIONS. The grade of crystals in monkey retinas was dose dependent with a threshold level at 0.6 mg canthaxanthin/kg body wt/d. It correlated in the retinal periphery with the concentrations of all-trans-canthaxanthin and in the macula with its metabolites.




This article has been cited by other articles:


Home page
IOVSHome page
M. Neuringer, M. M. Sandstrom, E. J. Johnson, and D. M. Snodderly
Nutritional Manipulation of Primate Retinas, I: Effects of Lutein or Zeaxanthin Supplements on Serum and Macular Pigment in Xanthophyll-Free Rhesus Monkeys
Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 3234 - 3243.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
P. H. Gann and F. Khachik
Tomatoes or Lycopene Versus Prostate Cancer: Is Evolution Anti-Reductionist?
J Natl Cancer Inst, November 5, 2003; 95(21): 1563 - 1565.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Association for Research in Vision and Ophthalmology